Yahoo Web Search

Search results

1. • 

     Moderna Investors Just Got Some Bullish News

     Motley Fool via Yahoo Finance· 17 hours ago

     So, even if Moderna shares don't take off overnight, the RSV approval is bullish news for shareholders -- and a great reason for other investors looking...

2. • 

     5 Top Stocks to Buy in June

     Motley Fool via Yahoo Finance· 2 days ago

     But investors don't have to wait until then to buy the stock. Shares look attractive today at 2.2 times revenue (down from 2.5 times revenue several...

3. • 

     Cathie Wood Owns These 2 AI Stocks. Should You?

     Motley Fool via Yahoo Finance· 16 hours ago

     Some might argue that it should be considered a tech stock, but until the technology it is implementing produces tangible results, it's hard to do much...

4. • 

     Norges Bank Buys New Holdings in Atlantic Union Bankshares Co. (NASDAQ:AUB)

     ETF DAILY NEWS· 20 hours ago

     The firm bought 517,300 shares of the company’s stock, valued at approximately $18,902,000. Several...

5. • 

     2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years

     Motley Fool via Yahoo Finance· 7 days ago

     Gilead Sciences should continue raising its payouts through 2034 and beyond. Should you invest...

6. • 

     3 No-Brainer Stocks to Buy in June | The Motley Fool

     The Motley Fool· 2 days ago

     You're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...

7. • 

     GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.

     InvestorPlace· 6 hours ago

     Many investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...

8. • 

     These S&P 500 stocks are cheap and well-liked by analysts heading into June

     CNBC· 4 days ago

     Several stocks, including a mass-market beauty retailer and a major biotech company, may be selling...

9. • 

     Why Summit Therapeutics Stock Is Sinking Today

     Motley Fool via Yahoo Finance· 6 days ago

     Is Summit Therapeutics stock a buy on the pullback? Some aggressive investors could view Summit ...think that most investors will be better off staying...

10. • Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Gap Up to $102.70

      ETF DAILY NEWS· 5 days ago

      Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report)’s stock price gapped up prior to trading on Tuesday . The stock< ...